U.S. Preventive Medicine(R) Awards Inaugural Global Prevention Prize to Dr. Valentin Fuster of Mount Sinai Heart
Posted on: Friday, 7 November 2008, 12:00 CST
DALLAS, Nov. 7 /PRNewswire/ -- U.S. Preventive Medicine(R), the leader in disease prevention, today announced Dr. Valentin Fuster, director of Mount Sinai Heart, the winner of its first-ever Global Prevention Prize. The Prize was presented to Dr. Fuster by veteran television journalist, Charlie Rose, during the inaugural National Health Science Summit held on November 7, 2008 in New York City.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080506/NETU129LOGO )
The Global Prevention Prize was created by U.S. Preventive Medicine to recognize and honor an individual who has demonstrated an ongoing commitment to prevention and its role in helping America and the world overcome paramount health care concerns. Additionally, this award seeks to acknowledge primary, secondary, or tertiary prevention achievements that improve the quality and longevity of individuals and groups, as well as help advance a culture of prevention. The award is presented at the annual National Health Science Summit, which is sponsored by U.S. Preventive Medicine and organized by the National Academy of Television Arts & Sciences.
"I am honored to receive the Global Prevention Prize and grateful to U.S. Preventive Medicine for such recognition," stated Dr. Fuster. "Mount Sinai Heart's efforts are broad and deep. Our laboratories and clinical facilities are bustling with investigation, patient evaluation, and treatments that bring patients the best modern science offers in the area of cardiac care. Some of our most exciting initiatives involve community service on distant shores and in distant venues. Cardiovascular disease is an international health priority, and I am proud that Mount Sinai Heart is playing a leading role in tackling this epidemic."
"It is a privilege to honor Dr. Fuster with this inaugural award designed to recognize those whose tireless efforts are making prevention a priority in overcoming global health care concerns," stated Christopher Fey, Chairman and CEO of U.S. Preventive Medicine. "Cardiovascular disease is the number one killer throughout the world. In the United States alone, the cost of treating cardiovascular disease doubled from approximately $150 billion a decade ago to about $300 billion in 2005. This trend will continue unless and until aggressive action is taken to prevent heart disease and promote healthy living. Prevention projects overseen by Dr. Fuster are making significant strides in educating and modifying behaviors in Africa, Colombia, Grenada, Spain, and the United States."
The first annual National Health Science Summit serves as a critical forum for 250 world-leading scientists, top journalists, health policy experts and executives to discuss trends in drug discovery and innovation, healthcare policy and legislation, and explore the frontiers of science, the breakthrough therapies and the implications for global health. Additional awards were presented by notable guests, including former NBA star Earvin "Magic" Johnson.
About Dr. Valentin Fuster
Dr. Fuster is Director of Mount Sinai Heart, Director of the Zena and Michael A. Wiener Cardiovascular Institute, and the Marie-Josee and Henry R. Kravis Center for Cardiovascular Health. He is also the Richard Gorlin, MD/Heart Research Foundation Professor at the Mount Sinai Medical Center and President of Science of the Centor Nacional de Investigaciones Cardiovacalures Carlos III (CNIC) in Madrid. He is a past president of the American Heart Association and the World Heart Federation. Under Dr. Fuster's leadership, Mount Sinai Heart is shaping a new paradigm in cardiovascular care in which clinicians are focused on treating and preventing disease, and promoting optimal heart health around the world.
About U.S. Preventive Medicine
U.S. Preventive Medicine(R), a privately-owned global prevention services company with clients nationwide and the United Kingdom, provides primary, secondary and tertiary clinical prevention services to government, employers and consumers that are data-driven and outcomes-oriented. Company products include the world's first preventive health benefit, The Prevention Plan(TM), available to buy or test drive at http://www.uspreventivemedicine.com/ and http://www.thepreventionplan.com/
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20080506/NETU129LOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.com
U.S. Preventive Medicine
CONTACT: Kathy Fleming of U.S. Preventive Medicine, +1-904-562-6239(office) or +1-214-548-9083 (cell), kfleming@USPreventiveMedicine.com
Web site: http://www.uspreventivemedicine.com/http://www.thepreventionplan.com/
Source: PRNewswire
Related Articles
- Mount Sinai Finds Those With More Difficult To Treat Forms Of HCV Are Half As Likely To Get Treated
- Lowering Cholesterol May Not Prevent Heart Disease
- The Mount Sinai Medical Center Selects Symantec for Endpoint Data Loss Prevention
- Mount Sinai School of Medicine and Medisyn Technologies Announce Agreement to Discover Novel Therapeutics for Treating Alzheimer's Disease
- Mount Sinai Medical Center Implants First New Device for Heart Failure Patients in Florida
- Mount Sinai School of Medicine and EXACT Sciences Announce Publication of Multi-Center Study Results on Stool DNA Testing for Colon Cancer
- Humanetics Signs Exclusive License With Mount Sinai School of Medicine to Develop Oral Agent to Combat Alzheimer's Disease
- U.S. Genomics Places First Trilogy Instrument With Mount Sinai School of Medicine; Trilogy Platform Facilitates Groundbreaking Research
- How Blood Pressure Pill Prevents Heart Attacks
 |
 |
User Comments (0)
RSS Feeds